A - Human Necessities – 01 – N
Patent
A - Human Necessities
01
N
A01N 37/00 (2006.01) A01N 37/10 (2006.01) A01N 37/12 (2006.01) A01N 37/18 (2006.01) A01N 37/44 (2006.01) A61K 31/16 (2006.01) A61K 31/165 (2006.01) A61K 31/215 (2006.01) A61K 31/235 (2006.01) A61K 31/24 (2006.01)
Patent
CA 2559972
The invention provides a therapeutic method for preventing or treating a pathological condition or symptom in a mammal, such as a human, wherein the infectivity of a pathogen such as a retrovirus toward mammalian cells is implicated and inhibition of its infectivity is desired comprising administering to a mammal in need of such therapy, an effective amount of procaine, procainamide or an analog thereof that inhibits pathogenic infectivity, including pharmaceutically acceptable salts thereof.
L'invention concerne un procédé thérapeutique pour la prévention ou le traitement d'un état ou d'un symptôme pathologique chez un mammifère, tel qu'un être humain, pour lequel l'infectivité d'un pathogène tel qu'un rétrovirus à l'égard des cellules de mammifère est impliquée, et pour lequel l'inhibition de ladite infectivité est désirée. Le procédé consiste à administrer à un mammifère nécessitant un tel traitement, une quantité efficace de procaïne, procaïnamide ou un analogue de ces composés inhibant l'infectivité pathogène, y compris les sels pharmaceutiquement acceptables de ces composés.
Greeson Janet
Lecanu Laurent
Papadopoulos Vassilios
Georgetown University
Goudreau Gage Dubuc
Samaritan Pharmaceuticals Inc.
LandOfFree
Benzamide and benzoate anti-hiv compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzamide and benzoate anti-hiv compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzamide and benzoate anti-hiv compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1362478